πŸ‡ΊπŸ‡Έ FDA
Patent

US 9463186

Treatment for dopaminergic disorders

granted A61KA61K31/135A61K31/4439

Quick answer

US patent 9463186 (Treatment for dopaminergic disorders) held by Northwestern University expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/135, A61K31/4439